Gilead CEO promises to make remdesivir affordable

The antiviral remdesivir has shown promise for treating coronavirus, and the head of the drug’s maker, Gilead Sciences, said he’s committed to ensuring anyone who needs the drug will have access to it.  ‘We’re going to work very closely with the government and with health care systems to make sure that it’s accessible, that it’s … Read more